Base excision repair accessory factors in senescence avoidance and resistance to treatments

Abstract

Cancer cells, in which the RAS and PI3K pathways are activated, produce high levels of reactive oxygen species (ROS), which cause oxidative DNA damage and ultimately cellular senescence. This process has been documented in tissue culture, mouse models, and human pre-cancerous lesions. In this context, cellular senescence functions as a tumour suppressor mechanism. Some rare cancer cells, however, manage to adapt to avoid senescence and continue to proliferate. One well-documented mode of adaptation involves increased production of antioxidants often associated with inactivation of the KEAP1 tumour suppressor gene and the resulting upregulation of the NRF2 transcription factor. In this review, we detail an alternative mode of adaptation to oxidative DNA damage induced by ROS: the increased activity of the base excision repair (BER) pathway, achieved through the enhanced expression of BER enzymes and DNA repair accessory factors. These proteins, exemplified here by the CUT domain proteins CUX1, CUX2, and SATB1, stimulate the activity of BER enzymes. The ensued accelerated repair of oxidative DNA damage enables cancer cells to avoid senescence despite high ROS levels. As a by-product of this adaptation, these cancer cells exhibit increased resistance to genotoxic treatments including ionizing radiation, temozolomide, and cisplatin. Moreover, considering the intrinsic error rate associated with DNA repair and translesion synthesis, the elevated number of oxidative DNA lesions caused by high ROS leads to the accumulation of mutations in the cancer cell population, thereby contributing to tumour heterogeneity and eventually to the acquisition of resistance, a major obstacle to clinical treatment.

Keywords

Base excision repair / reactive oxygen species, DNA repair accessory factor, oxidative DNA damage, resistance to treatment, tumour heterogeneity, acquisition of resistance

References

[1] Dianov GL.Mammalian base excision repair: the forgotten archangel.Nucleic Acids Res2013;41:3483-90 PMCID:PMC3616742

[2] Wilson DM.The mechanics of base excision repair, and its relationship to aging and disease.DNA repair2007;6:544-59

[3] Demple B.Repair of oxidative damage to DNA: enzymology and biology.Annu Rev Biochem1994;63:915-48

[4] Hegde ML,Mitra S.Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells.Cell Res2008;18:27-47 PMCID:PMC2692221

[5] Weinfeld M,Abdou I,Glover JN.Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair.Trends Biochem Sci2011;36:262-71 PMCID:PMC3134258

[6] Demple B.Molecular and biological roles of Ape1 protein in mammalian base excision repair.DNA Repair (Amst)2005;4:1442-9

[7] Wiederhold L,Kedar P,Rasouli-Nia A,Tomkinson AE,Prasad R,Mitra S.AP endonuclease-independent DNA base excision repair in human cells.Mol Cell2004;15:209-20

[8] Allinson SL,II .DNA polymerase beta is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts.EMBO J2001;20:6919-26 PMCID:PMC125762

[9] Horton JK,Hou E.Protection against methylation-induced cytotoxicity by DNA polymerase beta-dependent long patch base excision repair.J Biol Chem2000;275:2211-8

[10] Sobol RW,Nakamura J,Hou E,Ladapo J,Swenberg JA,Samson LD.Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress.Proc Natl Acad Sci USA2002;99:6860-5 PMCID:PMC124494

[11] Kunkel TA.The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation.J Biol Chem1986;261:160-6

[12] Lindahl T.Repair of endogenous DNA damage.Cold Spring Harb Symp Quant Biol2000;65:127-33

[13] Friedberg EC,Siede W. DNA Repair and Mutagenesis. Washington, DC: ASM Press; 2006. Available from: https://onlinelibrary.wiley.com/doi/book/10.1128/9781555816704 [Last accessed on 6 Jun 2022]

[14] Starcevic D,Sweasy JB.Is there a link between DNA polymerase beta and cancer?.Cell Cycle2004;3:998-1001Available from: https://www.tandfonline.com/doi/abs/10.4161/cc.3.8.1062 [Last accessed on 6 Jun 2022]

[15] Lang T,Starcevic D,Sweasy JB.A DNA polymerase beta mutant from colon cancer cells induces mutations.Proc Natl Acad Sci USA2004;101:6074-9 PMCID:PMC395925

[16] Sweasy JB,Starcevic D,Lai CC,Dalal S.Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation.Proc Natl Acad Sci USA2005;102:14350-5 PMCID:PMC1242307

[17] Al-Tassan N,Maynard J.Inherited variants of MYH associated with somatic G:C-->T:a mutations in colorectal tumors.Nat Genet2002;30:227-32.

[18] Banda DM,Burnside MA,David SS.Repair of 8-oxoG:a mismatches by the MUTYH glycosylase: mechanism, metals and medicine.Free Radic Biol Med2017;107:202-15 PMCID:PMC5457711

[19] Cheadle JP.MUTYH-associated polyposis--from defect in base excision repair to clinical genetic testing.DNA Repair (Amst)2007;6:274-9

[20] Sampson JR,Jones S.Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. The Lancet 2003;362:39-41.

[21] Nielsen M,Vasen HF.MUTYH-associated polyposis (MAP).Crit Rev Oncol Hematol2011;79:1-16

[22] Chow E,Macrae F.Colorectal cancer and inherited mutations in base-excision repair.Lancet Oncol2004;5:600-6

[23] Hutchcraft ML,Kolesar JM.MUTYH as an emerging predictive biomarker in ovarian cancer.Diagnostics (Basel)2021;11:84 PMCID:PMC7825630

[24] Weren RD,Kets CM.A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer.Nat Genet2015;47:668-71

[25] Weren RD,Geurts van Kessel A,Hoogerbrugge N.NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?.J Pathol2018;244:135-42

[26] Das L,Sweasy JB.NTHL1 in genomic integrity, aging and cancer.DNA Repair (Amst)2020;93:102920 PMCID:PMC7748067

[27] Dizdaroglu M.Base-excision repair of oxidative DNA damage by DNA glycosylases.Mutat Res2005;591:45-59

[28] Díaz-Gay M.Unraveling the genomic landscape of colorectal cancer through mutational signatures.Adv Cancer Res2021;151:385-424

[29] Slaga TJ,Nelson K.Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.Proc Natl Acad Sci USA1980;77:3659-63 PMCID:PMC349677

[30] Land H,Weinberg RA.Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.Nature1983;304:596-602

[31] Murray MJ,Shih C,Hsu HW.Three different human tumor cell lines contain different oncogenes.Cell1981;25:355-61

[32] Pylayeva-Gupta Y,Bar-Sagi D.RAS oncogenes: weaving a tumorigenic web.Nat Rev Cancer2011;11:761-74 PMCID:PMC3632399

[33] Lim JKM.The impact of oncogenic RAS on redox balance and implications for cancer development.Cell Death Dis2019;10:955 PMCID:PMC6920345

[34] Sarkisian CJ,Stairs DB,Moody SE.Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.Nat Cell Biol2007;9:493-505

[35] Sinn E,Pattengale PK,Wallace R.Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.Cell1987;49:465-75

[36] Kelekar A.Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes.Mol Cell Biol1986;6:7-14

[37] Jochemsen AG,Bos JL.Transforming properties of a 15-kDa truncated Ad12 E1A gene product.Virology1986;152:375-83

[38] Asselin C.Sequences from polyomavirus and simian virus 40 large T genes capable of immortalizing primary rat embryo fibroblasts.J Virol1985;56:958-68 PMCID:PMC252670

[39] Levine AJ.The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp1989;20:221-30

[40] Luo J,Elledge SJ.Principles of cancer therapy: oncogene and non-oncogene addiction.Cell2009;136:823-37 PMCID:PMC2894612

[41] Sawyers CL,Feldman E.Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.Blood2002;99:3530-9

[42] Talpaz M,Druker BJ.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.Blood2002;99:1928-37

[43] Irani K,Zweier JL.Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.Science1997;275:1649-52

[44] Bessler WK,Zhang H.Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.Free Radic Biol Med2016;97:212-22

[45] Huo YY,Duan RF.PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts.Free Radic Biol Med2008;44:1578-91

[46] Mailloux RJ,O'Brien M.2-Oxoglutarate dehydrogenase is a more significant source of O2(·-)/H2O2 than pyruvate dehydrogenase in cardiac and liver tissue.Free Radic Biol Med2016;97:501-12

[47] Ilic N,Aguirre AJ.PIK3CA mutant tumors depend on oxoglutarate dehydrogenase.Proc Natl Acad Sci USA2017;114:E3434-e43. 10.1073/pnas.1617922114 PMCID:PMC5410781

[48] Jagadeeswaran R,Bindokas VP.Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.Am J Physiol Lung Cell Mol Physiol2007;292:L1488-94

[49] Koptyra M,Nowicki MO.BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.Blood2006;108:319-27 PMCID:PMC1895841

[50] Kim JH,Gramlich JL.Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.Blood2005;105:1717-23

[51] Koundouros N.Phosphoinositide 3-Kinase/Akt signaling and redox metabolism in cancer.Front Oncol2018;8:160 PMCID:PMC5968394

[52] Mitsushita J,Kamata T.The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation.Cancer Res2004;64:3580-5

[53] Weyemi U,Boufraqech M.ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence.Oncogene2012;31:1117-29 PMCID:PMC3307059

[54] Park MT,Suh Y.Novel signaling axis for ROS generation during K-Ras-induced cellular transformation.Cell Death Differ2014;21:1185-97 PMCID:PMC4085525

[55] Ogrunc M,Liontos M.Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation.Cell Death Differ2014;21:998-1012 PMCID:PMC4013514

[56] Maciag A,Anderson LM.Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells.Carcinogenesis2004;25:2231-7

[57] Kopnin PB,Kopnin BP.Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability.Cancer Res2007;67:4671-8 PMCID:PMC2657553

[58] Weinberg F,Wheaton WW.Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.Proc Natl Acad Sci USA2010;107:8788-93 PMCID:PMC2889315

[59] Liou GY,DelGiorno KE.Mutant KRas-Induced mitochondrial oxidative stress in acinar cells upregulates EGFR Signaling to drive formation of pancreatic precancerous lesions.Cell Rep2016;14:2325-36 PMCID:PMC4794374

[60] Budanov AV,Feinstein E,Chumakov PM.Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.Science2004;304:596-600

[61] Lee AC,Ito H.Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species.J Biol Chem1999;274:7936-40

[62] Collado M,Efeyan A.Tumour biology: senescence in premalignant tumours.Nature2005;436:642

[63] Dankort D,Collado M.A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.Genes Dev2007;21:379-84 PMCID:PMC1804325

[64] Bartkova J,Liontos M.Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.Nature2006;444:633-7

[65] Fujita K,Horikawa I.p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.Nat Cell Biol2009;11:1135-42 PMCID:PMC2802853

[66] Kuilman T,Vredeveld LC.Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.Cell2008;133:1019-31

[67] Michaloglou C,Soengas MS.BRAFE600-associated senescence-like cell cycle arrest of human naevi.Nature2005;436:720-4

[68] Courtois-Cox S,Reczek EE.A negative feedback signaling network underlies oncogene-induced senescence.Cancer Cell2006;10:459-72 PMCID:PMC2692661

[69] Campisi J.Aging, cellular senescence, and cancer.Annu Rev Physiol2013;75:685-705

[70] Moon DO,Jang JH.K-RAS transformation in prostate epithelial cell overcomes H2O2-induced apoptosis via upregulation of gamma-glutamyltransferase-2.Toxicol In Vitro2012;26:429-34

[71] Recktenwald CV,Lichtenfels R.Altered detoxification status and increased resistance to oxidative stress by K-ras transformation.Cancer Res2008;68:10086-93

[72] Young TW,Yang G.Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.Cancer Res2004;64:4577-84

[73] Jeon SM,Hay N.AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.Nature2012;485:661-5 PMCID:PMC3607316

[74] Kerr EM,Turrell FK,Martins CP.Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities.Nature2016;531:110-3 PMCID:PMC4780242

[75] Lim JKM,Minaker SW.Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.Proc Natl Acad Sci USA2019;116:9433-42 PMCID:PMC6511045

[76] Son J,Ying H.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.Nature2013;496:101-5 PMCID:PMC3656466

[77] Venugopal R.Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes.Oncogene1998;17:3145-56

[78] Itoh K,Katoh Y.Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.Genes Dev1999;13:76-86 PMCID:PMC316370

[79] Shibata T,Tong KI.Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.Proc Natl Acad Sci USA2008;105:13568-73 PMCID:PMC2533230

[80] Ohta T,Miyamoto M.Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.Cancer Res2008;68:1303-9

[81] Nioi P.A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity.Biochem Biophys Res Commun2007;362:816-21.

[82] Singh A,Thimmulappa RK.Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.PLoS Med2006;3:e420 PMCID:PMC1584412

[83] Padmanabhan B,Ohta T.Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.Mol Cell2006;21:689-700

[84] Hayes JD.NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.Trends Biochem Sci2009;34:176-88

[85] DeNicola GM,Humpton TJ.Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.Nature2011;475:106-9 PMCID:PMC3404470

[86] Srivastava DK,Arteaga CL.DNA polymerase beta expression differences in selected human tumors and cell lines.Carcinogenesis1999;20:1049-54

[87] Albertella MR,O'Connor MJ.The overexpression of specialized DNA polymerases in cancer.DNA Repair (Amst)2005;4:583-93

[88] Canitrot Y,Astarie-Dequeker C.Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia.Anticancer Res2006;26:523-5

[89] Moore DH,Tritt R,Kelley MR.Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.Clin Cancer Res2000;6:602-9.

[90] Kelley MR,Foster R.Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.Clin Cancer Res2001;7:824-30.

[91] Bobola MS,Berger MS,Silber JR.Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.Clin Cancer Res2001;7:3510-8

[92] Wang D,Kelley MR.Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.Mol Cancer Ther2004;3:679-86

[93] Santana T,de Moura Santos E.DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma.J Oral Pathol Med2017;46:496-503

[94] Sato M,Sekine I.Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer.Oncogene2003;22:7243-6

[95] Iacobuzio-Donahue CA,Olsen M.Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.Am J Pathol2003;162:1151-62 PMCID:PMC1851213

[96] Krause A,Iacono I.Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.Cancer Lett2005;225:111-20.

[97] Kim JM,Yoon SY.Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells.Clin Cancer Res2005;11:473-82

[98] LaTulippe E,Smith A.Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.Cancer Res2002;62:4499-506

[99] Luo J,Li D.A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.Cell2009;137:835-48 PMCID:PMC2768667

[100] Ramdzan ZM,Pal R.RAS transformation requires CUX1-dependent repair of oxidative DNA damage.PLoS Biology2014;12:e1001807 PMCID:PMC3949673

[101] Kaur S,Guiot MC.CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the Mono-Alkylating agent, temozolomide.Neuro Oncol2018;20:484-93 PMCID:PMC5909652

[102] Ramdzan ZM,Li L.CUT domains stimulate pol beta enzymatic activities to accelerate completion of base excision repair.J Mol Biol2021;433:166806

[103] Wang T,Hughes NW.Identification and characterization of essential genes in the human genome.Science2015;350:1096-101 PMCID:PMC4662922

[104] Ellis T,Horcher M.The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle.Genes Dev2001;15:2307-19 PMCID:PMC312776

[105] Sinclair AM,Goldstein A.Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice.Blood2001;98:3658-67.

[106] Luong MX,Xing D.Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertility.Mol Cell Biol2002;22:1424-37 PMCID:PMC134686

[107] Ramdzan ZM,Kaur S.The function of CUX1 in oxidative DNA damage repair is needed to prevent premature senescence of mouse embryo fibroblasts.Oncotarget2015;6:3613-26 PMCID:PMC4414141

[108] Network TCGA.Comprehensive molecular characterization of human colon and rectal cancer.Nature2012;487:330-7 PMCID:PMC3401966

[109] Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.Nature2008;455:1061-8 PMCID:PMC2671642

[110] Michl P,Pardo OE.CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.Cancer Cell2005;7:521-32

[111] Ripka S,Buchholz M.WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.Carcinogenesis2007;28:1178-87

[112] Ripka S,Riedel J.CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer.Gut2010;59:1101-10

[113] Ramdzan ZM,Pinder JB.The DNA repair function of CUX1 contributes to radioresistance.Oncotarget2017;8:19021-38 PMCID:PMC5386666

[114] Cubelos B,Beccari L.Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex.Neuron2010;66:523-35 PMCID:PMC2894581

[115] Yamada M,McClelland C.Cux2 activity defines a subpopulation of perinatal neurogenic progenitors in the hippocampus.Hippocampus2015;25:253-67 PMCID:PMC4312975

[116] Iulianella A,Vanden Heuvel GB.Cux2 functions downstream of Notch signaling to regulate dorsal interneuron formation in the spinal cord.Development (Suppl)2009;136:2329-34 PMCID:PMC2729345

[117] Conforto TL,Sherman J.Impact of Cux2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.Mol Cell Biol2012;32:4611-27 PMCID:PMC3486175

[118] Quaggin SE,Golden K,Igarashi P.Primary structure, neural-specific expression, and chromosomal localization of Cux-2, a second murine homeobox gene related to drosophila cut.J Biol Chem1996;271:22624-34

[119] Kohwi-Shigematsu T,Ordinario E.Genome organizing function of SATB1 in tumor progression.Semin Cancer Biol2013;23:72-9 PMCID:PMC4048061

[120] Cai S,Kohwi-Shigematsu T.Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003;34:42-51.

[121] Yasui D,Cai S,Kohwi-Shigematsu T.SATB1 targets chromatin remodelling to regulate genes over long distances.Nature2002;419:641-5

[122] Han H-J,Kohwi Y.SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.Nature2008;452:187-93

[123] Chen H,Oba J.Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.J Dermatol Sci2011;64:39-44

[124] Cheng C,Wang G.Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features: SATB1 and heparanase in gastric cancer. APMIS 2010;118:855-63.

[125] Mir R,Patil P,Galande S.Wnt/beta-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.Oncogene2016;35:1679-91

[126] Pal R,Kaur S.CUX2 functions as an accessory factor in the repair of oxidative DNA damage.J Biol Chem2015;290:22520-31 PMCID:PMC4566227

[127] Kaur S,Ramdzan ZM.Special AT-rich sequence-binding protein 1 (SATB1) functions as an accessory factor in base excision repair.J Biol Chem2016;291:22769-80 PMCID:PMC5077210

[128] Marcotte R,Suarez F.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Cancer discov2012;2:172-89 PMCID:PMC5057396

[129] Das S,Bhakat KK.Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress.J Biol Chem2007;282:28474-84 PMCID:PMC2679419

[130] Hegde ML,Hegde PM.Enhancement of NEIL1 protein-initiated oxidized DNA base excision repair by heterogeneous nuclear ribonucleoprotein U (hnRNP-U) via direct interaction.J Biol Chem2012;287:34202-11 PMCID:PMC3464528

[131] Prasad R,Deterding LJ.HMGB1 is a cofactor in mammalian base excision repair.Mol Cell2007;27:829-41 PMCID:PMC2799894

[132] Charles Richard JL,Menoni H.FACT assists base excision repair by boosting the remodeling activity of RSC.PLoS Genet2016;12:e1006221 PMCID:PMC4965029

[133] Zhou J,Wilson SH.A role for p53 in base excision repair.EMBO J2001;20:914-23 PMCID:PMC145418

[134] Illuzzi JL,3rd .Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigms.Curr Med Chem2012;19:3922-36 PMCID:PMC4537170

[135] Canitrot Y,Frechet M.Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.Proc Natl Acad Sci USA1998;95:12586-90 PMCID:PMC22874

[136] Tan X,Luo G.Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer.Int J Biol Sci2015;11:144-55 PMCID:PMC4279090

[137] Tang JB,Trivedi RN.N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.Neuro Oncol2011;13:471-86 PMCID:PMC3093332

[138] Trivedi RN,Fornsaglio JL,Sobol RW.The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.Cancer Res2005;65:6394-400

[139] Trivedi RN,Jelezcova E.Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.Mol Pharmacol2008;74:505-16 PMCID:PMC3909956

[140] Jaiswal AS,Panda H.A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.Mol Cancer Res2009;7:1973-83 PMCID:PMC2796282

[141] Jaiswal AS,Law BK.NSC666715 and its analogs inhibit strand-displacement activity of DNA polymerase beta and potentiate temozolomide-induced DNA damage, senescence and apoptosis in colorectal cancer cells.PLoS One2015;10:e0123808 PMCID:PMC4416822

[142] Sobol RW,Kuhn R.Requirement of mammalian DNA polymerase-beta in base-excision repair.Nature1996;379:183-6

[143] Arian D,Zhou H.Irreversible inhibition of DNA polymerase beta by small-molecule mimics of a DNA lesion. J Am Chem Soc 2014;136:3176-83. PMCID:PMC4047187

[144] Jelezcova E,Wang XH.Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage.Mutat Res2010;686:57-67 PMCID:PMC2834876

[145] Horton JK.Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency.DNA Repair (Amst)2007;6:530-43 PMCID:PMC1911606

[146] Horton JK,Joyce-Gray DF.Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions.DNA Repair2003;2:27-48

[147] Yang J,Nicolay NH.Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.Oncogene2010;29:463-8

[148] Horton JK,Zmudzka BZ.Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents. DNA Repair 1995;23:3810-5. PMCID:PMC307295

[149] Silber JR,Blank A.The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.Clin Cancer Res2002;8:3008-18

[150] Bobola MS,Blank A.Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy.Clin Cancer Res2004;10:7875-83

[151] Bobola MS,Ellenbogen RG.Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.Clin Cancer Res2005;11:7405-14

[152] Luo M.Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.Anticancer Res2004;24:2127-34

[153] McNeill DR,DeWeese TL,Wilson DM 3rd.Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.Mol Cancer Res2009;7:897-906 PMCID:PMC2745049

[154] Rai G,Dorjsuren D.Small molecule inhibitors of the human apurinic/apyrimidinic endonuclease 1 (APE1). In: probe reports from the NIH molecular libraries program. Bethesda (MD);2010.

[155] Montaldi AP,Sakamoto-Hojo ET.APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.Mutat Res Genet Toxicol Environ Mutagen2015;793:19-29

[156] Liu L,Taverna P.Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.Clin Cancer Res1999;5:2908-17

[157] Taverna P,Hwang HS.Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.Mutat Re485:269-81

[158] Liu L,Gerson SL.Base excision repair as a therapeutic target in colon cancer.Clin Cancer Res2002;8:2985-91

[159] Larsen E,Saether BE,Klungland A.Proliferation failure and gamma radiation sensitivity of Fen1 null mutant mice at the blastocyst stage.Mol Cell Biol2003;23:5346-53 PMCID:PMC165721

[160] Urbanucci A,Seppala J.Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.Oncogene2012;31:2153-63

[161] Agnihotri S,Buczkowicz P.ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.Cancer Discov2014;4:1198-213 PMCID:PMC4184920

[162] Agnihotri S,Ternamian C.Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.J Clin Invest2012;122:253-66 PMCID:PMC3248301

[163] Hermens AF.Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line.Cancer Res1992;52:3073-82

[164] Bernhard EJ,Cox AD.The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.Cancer Res1996;56:1727-30

[165] McKenna WG,Bakanauskas VJ.The role of the H-ras oncogene in radiation resistance and metastasis.Int J Radiat Oncol Biol Phys1990;18:849-59

[166] Miller AC,Myers CE,Samid D.Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation.Int J Cancer1993;53:302-7

[167] Koptyra M,Slupianek A,Skorski T.BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.Leukemia2008;22:1969-72 PMCID:PMC3857962